Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Epilepsies, Myoclonic, Date of authorisation: 18/12/2020, Revision: 6, Status: Authorised
TO: